tiprankstipranks
Trending News
More News >
Arcutis Biotherapeutics Inc (ARQT)
:ARQT
US Market
Advertisement

Arcutis Biotherapeutics (ARQT) Ownership - Who Owns Arcutis Biotherapeutics?

Compare
865 Followers

Arcutis Biotherapeutics (ARQT) Ownership Overview

9.96%17.90%0.38%12.89%58.87%
0.38% Other Institutional Investors
12.89% ETFs
58.87% Public Companies and Individual Investors
The ownership structure of Arcutis Biotherapeutics (ARQT) stock is a mix of institutional, retail, and individual investors. Approximately 31.17% of the company’s stock is owned by Institutional Investors, 9.96% is owned by Insiders, and 58.87% is owned by Public Companies and Individual Investors.
The ownership structure of Arcutis Biotherapeutics (ARQT) stock is a mix of institutional, retail, and individual investors. Approximately 18.28% of the company’s stock is owned by Institutional Investors, 9.96% is owned by Insiders, and 12.89% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 05, 2025
xxxxxxxxxxxxx
$1274
Aug 05, 2025
xxxxxxxxxxxxx
$37547
Aug 05, 2025
xxxxxxxxxxxxx
$165353
Jun 17, 2025
xxxxxxxxxxxxx
$34610

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$322997
Mar 31, 2025
xxxxxxxxxxxxx
$588329
Mar 31, 2025
xxxxxxxxxxxxx
$4185451
Mar 31, 2025
xxxxxxxxxxxxx
$6412400

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,862,862Insider7.44%136,488,075
6,167,912Institution5.17%94,985,845
4,948,983Institution4.15%76,214,338
4,870,002Institution4.09%74,998,031
4,096,051Institution3.44%63,079,185
3,085,198Institution2.59%47,512,049
2,524,820Institution2.12%38,882,228
2,142,393Institution1.80%32,992,852
1,358,500Institution1.14%20,920,900
1,334,049Institution1.12%20,544,355

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,948,983Institution4.15%76,214,338
3,085,198Institution2.59%47,512,049
2,524,820Institution2.12%38,882,228
1,334,049Institution1.12%20,544,355
1,177,269Institution0.99%18,129,943
1,041,033Institution0.87%16,031,908
965,545Institution0.81%14,869,393
822,815Institution0.69%12,671,351
599,905Institution0.50%9,238,537
579,576Institution0.49%8,925,470

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,444,250Institution2.89%44,913,020
2,729,025Institution2.29%43,391,498
1,927,617Institution1.62%28,933,531
1,653,435Institution1.39%21,560,792
942,548Institution0.79%14,986,513
652,687Institution0.55%10,377,723
543,830Institution0.46%7,091,543
502,956Institution0.42%7,549,370
407,079Institution0.34%6,472,556
333,916Institution0.28%4,354,265

FAQ

Who Owns Arcutis Biotherapeutics Inc (ARQT)?
According to the latest TipRanks data, approximately 0.38% of the company's stock is held by institutional investors, 9.96% is held by insiders, and 58.87% is held by retail investors.
    What percentage of Arcutis Biotherapeutics Inc (ARQT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.38% of Arcutis Biotherapeutics Inc (ARQT) stock is held by institutional investors.
      What percentage of Arcutis Biotherapeutics Inc (ARQT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.87% of Arcutis Biotherapeutics Inc (ARQT) stock is held by retail investors.
        Who owns the most shares of Arcutis Biotherapeutics Inc (ARQT)?
        Patrick Heron owns the most shares of Arcutis Biotherapeutics Inc (ARQT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis